WG
ATRC icon

Winton Group’s AtriCure ATRC Stock Holding History

Winton Group’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-21,743
Closed -$730K – 1444
2020
Q1 		$730K Sell
21,743
-271
-1% -$9.74K 0.02% 910
2019
Q4 		$716K Buy
+22,014
New +$626K 0.01% 1143
2019
Q2 		– Sell
-9,083
Closed -$243K – 1123
2019
Q1 		$243K Buy
+9,083
New +$276K ﹤0.01% 886

Other funds holding ATRC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Winton Group's ATRC Position: Q2 2020 in Review

Winton Group sold out of AtriCure (ATRC) in Q2 2020, closing a stake of 21,743 shares — an estimated $730K sold.

Winton Group first reported a position in ATRC in Q1 2019 and held it in 3 quarters. The position peaked at $730K in Q1 2020. 188 funds tracked by Wall St. Rank hold ATRC as of Q2 2020.

  • Winton Group reported no remaining AtriCure position as of Q2 2020 after selling out during the quarter.
  • Winton Group sold 21,743 AtriCure shares in Q2 2020, an estimated $730K.
  • Winton Group first reported a position in AtriCure in Q1 2019 and held it in 3 quarters.
  • Winton Group's AtriCure position peaked at $730K in Q1 2020.
  • 188 funds tracked by Wall St. Rank held AtriCure as of Q2 2020.

Based on Winton Group's 13F filing for Q2 2020, filed 5 Aug 2020.